Online ISSN: Request pending
Published quarterly by Wissira Research Lab.
The International Journal of Pharmaceutical Creativity and Innovation (IJPCI) is committed to maintaining the highest standards of academic integrity, originality, transparency, responsible research, and ethical scholarly publishing. The journal strictly prohibits plagiarism, duplicate publication, fabrication, falsification, copyright infringement, unethical authorship, and other forms of research or publication misconduct.
Authors are expected to submit only original scholarly work that has been prepared through responsible research practices and that has not been copied, fabricated, falsified, improperly reproduced, or simultaneously submitted to another journal.
IJPCI maintains a rigorous editorial and peer-review process. Similarity reports, citation practices, authorship declarations, research ethics, copyright compliance, data integrity, and responsible use of Artificial Intelligence (AI) may all be considered during editorial evaluation.
Plagiarism is the presentation of another person's words, ideas, data, figures, tables, concepts, methods, interpretations, or other intellectual contributions as one's own without appropriate acknowledgment.
Plagiarism includes, but is not limited to:
Direct plagiarism occurs when text is copied word-for-word from another source without quotation marks and appropriate citation. For example, copying a paragraph from a published pharmaceutical research article and presenting it as original writing is considered plagiarism.
Mosaic plagiarism occurs when phrases, sentence structures, or passages from multiple sources are combined with minor modifications while retaining the original intellectual structure without adequate attribution.
Paraphrasing plagiarism occurs when an author changes a few words or rearranges sentences from an original source but fails to provide appropriate citation. Proper paraphrasing requires genuine rewriting in the author's own scholarly expression together with acknowledgment of the original source.
Idea plagiarism occurs when an author presents another researcher's unique concept, hypothesis, theoretical framework, methodology, interpretation, or intellectual contribution as their own without acknowledgment.
Data plagiarism includes unauthorized use or presentation of another researcher's datasets, tables, graphs, images, experimental results, or statistical findings as original work.
Self-plagiarism occurs when authors reuse substantial portions of their own previously published work without appropriate citation, disclosure, or justification. Reuse of previously published material must be transparent and must not mislead readers regarding the originality of the submitted manuscript.
All manuscripts submitted to IJPCI may undergo plagiarism and similarity screening using recognized similarity-detection software before or during editorial evaluation.
The editorial office may examine similarity reports for:
The similarity percentage alone does not establish plagiarism. Editorial assessment will consider the source, location, nature, extent, context, citation status, and originality of the overlapping material.
As an IJPCI editorial policy, the journal expects the overall similarity of a submitted manuscript to be below 10%, excluding legitimate references, bibliography entries, properly identified quotations, and unavoidable technical or scientific terminology where applicable.
The 10% threshold is an IJPCI editorial requirement.
Authors should therefore aim for genuinely original scholarly writing rather than merely attempting to achieve a particular similarity percentage.
A manuscript with 5% similarity may still constitute plagiarism if the 5% represents copied original ideas, text, data, figures, or findings without attribution. Conversely, a higher similarity score may sometimes arise from references, standardized methodology, technical terminology, or properly cited material. Therefore, editorial judgment remains decisive.
If plagiarism or serious similarity concerns are identified before publication, IJPCI may take one or more of the following actions depending on the severity and circumstances:
If plagiarism, fabrication, falsification, copyright infringement, or another serious publication-ethics violation is discovered after publication, IJPCI may investigate the matter and take appropriate corrective action.
IJPCI recognizes that Artificial Intelligence and AI-assisted technologies can support researchers in literature organization, language improvement, data-analysis workflows, research planning, and other legitimate scholarly activities. However, AI must not replace the author's intellectual contribution, scientific judgment, critical evaluation, responsibility, or accountability.
Current scholarly publishing guidance emphasizes human oversight and requires authors to verify AI-generated material, including references and factual claims. Authors remain responsible for the accuracy, originality, integrity, and legality of the submitted work.
Subject to responsible human oversight, AI tools may be used for activities such as:
Basic spelling, grammar, and punctuation checks generally do not require a separate AI declaration under current Elsevier journal guidance. However, substantive AI assistance that changes sentence structure, organization, or generates content should be disclosed where required.
Authors must not use AI systems to:
Current publisher guidance specifically warns that AI-generated references may be incorrect or fabricated and that authors must independently verify them.
Artificial Intelligence tools cannot be listed as authors or co-authors of an IJPCI manuscript. Authorship requires human responsibility, accountability, approval of the final manuscript, and the ability to address questions concerning the integrity of the research.
Authors remain fully responsible for all content submitted to the journal, regardless of whether any portion of the manuscript was prepared with AI assistance.
Where generative AI or AI-assisted technologies have been used in manuscript preparation beyond basic spelling, grammar, or punctuation checking, authors should provide a clear disclosure describing the tool used, its purpose, and the extent of human review and oversight.
Recommended declaration format:
If AI tools are used as part of the actual research methodology, including data analysis, coding, image processing, or other research procedures, the relevant use should be described in the Methods section where scientifically appropriate.
Authors are personally and collectively responsible for checking all AI-assisted content before submission. This includes verification of factual claims, scientific statements, statistical interpretations, references, citations, quotations, tables, figures, and conclusions.
Authors must not assume that AI-generated information is accurate merely because it is presented in authoritative or academic language. Any inaccurate, fabricated, misleading, or unverifiable content remains the responsibility of the authors.
Authors must ensure that submitted manuscripts do not infringe the copyright, trademark, patent, database rights, privacy rights, or other intellectual-property rights of third parties.
Authors are responsible for:
Copyright infringement may be treated as a publication-ethics violation independently of the similarity percentage. A manuscript can therefore be rejected even where its overall similarity score is below 10% if it contains unauthorized reproduction of protected material.
Authors must provide accurate, complete, and consistent citations for all sources that contribute to the manuscript. Every source cited in the text should appear in the reference list, and every reference included in the reference list should be appropriately cited within the manuscript, except where the chosen citation system provides a specific exception.
References must be authentic, traceable, and relevant to the claims they support. Authors are responsible for checking bibliographic details, DOI information where applicable, publication titles, author names, publication years, page information, and URLs where required.
IJPCI accepts recognized and consistently applied academic referencing systems, subject to the requirements specified for the particular article type or discipline. Authors may use:
Authors must not mix citation systems inconsistently within the same manuscript. The selected style should be applied consistently to in-text citations, footnotes where applicable, and the final reference list.
Improper: An author takes a published statement, changes two or three words, removes the original author's name, and presents the sentence as an original statement.
Proper: The author substantially rewrites the concept in their own scholarly language and cites the original publication.
Improper: A figure from another research article is reproduced without attribution or permission where permission is required.
Proper: The figure is cited, identified as reproduced or adapted, and appropriate permission is obtained where legally necessary.
Improper: An AI system generates five references and the author inserts them without checking whether the papers actually exist.
Proper: The author independently verifies every reference against a reliable scholarly source before including it in the manuscript.
IJPCI strictly prohibits fabrication and falsification of research.
Fabrication or falsification may result in immediate rejection and, where discovered after publication, may result in correction, expression of concern, retraction, and notification of appropriate institutions or authorities.
IJPCI does not accept:
Authors must disclose any related manuscripts, conference papers, preprints, datasets, dissertations, or previously published materials that substantially overlap with the submitted manuscript.
Every submitting author is responsible for ensuring that:
Failure to provide proper references can constitute plagiarism, intellectual-property infringement, or research misconduct depending on the circumstances.
Manuscripts may be returned for correction where citation omissions are minor and unintentional. However, deliberate concealment of sources, systematic unattributed copying, fabricated citations, or substantial intellectual-property misuse may result in rejection.
Authors remain responsible for verifying that every significant idea, statement, dataset, figure, table, method, quotation, or finding derived from another source is appropriately acknowledged.
Similarity screening is only one component of editorial assessment. Editors may also consider originality, methodological soundness, research significance, ethical compliance, data integrity, authorship, citation accuracy, copyright compliance, and responsible AI use.
The journal may request supporting information, original data, research documentation, ethical approval evidence, permissions, or explanations concerning similarity or publication-ethics concerns.
A manuscript may be rejected before or after peer review if the editorial team identifies serious concerns relating to:
Serious misconduct may result in rejection irrespective of the numerical similarity percentage.
The final decision regarding plagiarism, similarity, research misconduct, copyright concerns, AI-related issues, and publication ethics rests with the Editor-in-Chief and Editorial Board, based on the evidence available and the circumstances of each individual case.
The journal reserves the right to request clarification, documentation, corrections, revisions, additional declarations, or supporting evidence before making an editorial decision.
IJPCI is dedicated to promoting originality, transparency, responsible research, accurate attribution, ethical use of technology, and trustworthy scholarly communication. Authors, reviewers, editors, and readers share responsibility for maintaining the integrity of the academic record.
By submitting a manuscript to IJPCI, authors confirm that they have read and understood the journal's publication-ethics requirements and agree to take responsibility for the originality, accuracy, ethical integrity, appropriate attribution, and lawful use of materials contained in their submission.
Online ISSN: Request pending
Published quarterly by Wissira Research Lab.
Preparing a manuscript in pharmaceutical sciences? Review the journal scope and submission requirements before submitting.
For issue schedules and submission enquiries, contact editor@ijpci.org.
International Journal of Pharmaceutical Creativity and Innovation
Published by Wissira Research Lab
Online ISSN: Request pending